Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
about
Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.CIP2A influences survival in colon cancer and is critical for maintaining Myc expressionCancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.CIP2A is a target of bortezomib in human triple negative breast cancer cells.Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy.Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.Role of protein phosphatases in genitourinary cancers.BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro.Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients.The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma.CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
P2860
Q31137535-028F3D1B-4F12-4BEB-8D3C-B3C654E2680CQ33636463-068C8C8F-03CD-438E-83D7-CA4E7361923EQ33712856-A10106E6-D56A-480A-8C49-029ECB85CB1CQ33895872-05CDADD5-FDFA-42B6-8BE2-D0D96FA5EE3DQ35009096-4AFD4461-8ACF-4289-A94D-3C48B7D7F960Q35741656-29770007-D2D2-471B-A42D-F20A0E39C175Q35839042-3B77E19A-D3B0-411C-8834-E1CFB6D27E2DQ36069147-E9AED9F9-0726-495B-9980-04FBD4263516Q36245640-2635A515-0AEE-4DF3-ABB3-EB6CB58DEA15Q36887378-1D738414-9B7E-4E99-9140-0E8FD9C67C20Q36998120-E61A39C2-74CB-49C0-A7C1-D8155DCBB307Q37428639-C7A3265E-0980-4801-A54F-A16CB21992C5Q37581930-F311049C-9580-4274-985D-0D723ABE70A7Q37735594-E2AE8C09-5319-4E12-B515-CF9D602E0F10Q38228491-CE78C07B-4212-43B0-BAC7-8A32818B1DA0Q38401447-18C7AD74-077B-4E2B-B65F-BDD75E240061Q38870961-8464BD7E-6F4E-4806-B6FA-D6734ED56E66Q38914929-27EA4483-005E-4596-96F2-420FA7A69DF3Q38941676-CAB0E693-7AAA-4B99-A79F-147744F78DE6Q38990258-4F6D546E-275A-47D8-86EC-B556274E457DQ39039799-1A7ABF04-2026-473D-9A75-EC907198B728Q39098575-E2991D83-CC9A-4EA1-87E9-2FCE3D562032Q39218849-754EB75A-B783-461E-B208-A08CCB7C9858Q39252224-547383A7-0271-461C-AECB-805111DBBDCAQ41160985-EA6ADF27-854B-4607-BB39-787399CF06C5Q43459677-0BD8E9FB-A7AF-43AC-B5AC-13071204D6BFQ47110572-A1EAE8AB-E233-474C-8A0F-F74C07FF3F52Q47381126-6A8E7F9A-6CD6-4F00-A4AD-EA7A7489B7B1Q47832427-C4D8B5D6-38E6-4558-9203-AEE6C0DD966FQ51020266-2DFF15DA-8D9A-464C-959E-485A73F12BA5Q58545064-B2371056-3E6B-47BE-BD3B-C6BE1CB3249E
P2860
Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Expression of CIP2A in renal c ...... stasis and patients' survival.
@ast
Expression of CIP2A in renal c ...... stasis and patients' survival.
@en
type
label
Expression of CIP2A in renal c ...... stasis and patients' survival.
@ast
Expression of CIP2A in renal c ...... stasis and patients' survival.
@en
prefLabel
Expression of CIP2A in renal c ...... stasis and patients' survival.
@ast
Expression of CIP2A in renal c ...... stasis and patients' survival.
@en
P2093
P2860
P356
P1476
Expression of CIP2A in renal c ...... stasis and patients' survival.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.492
P407
P577
2011-11-10T00:00:00Z
P5875
P6179
1011100596